Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer
Crossref DOI link: https://doi.org/10.1186/s12890-020-01210-x
Published Online: 2020-06-18
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, Tian
Lin, Yong
Zeng, Qingdi
Yao, Wei
Han, Liping
Text and Data Mining valid from 2020-06-18
Version of Record valid from 2020-06-18
Article History
Received: 18 March 2019
Accepted: 8 June 2020
First Online: 18 June 2020
Ethics approval and consent to participate
: Not applicable.
: None.